Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum
2007

Impact of Host Immunity on Malaria Treatment in Tanzanian Children

Sample size: 100 publication 10 minutes Evidence: moderate

Author Information

Author(s): Enevold Anders, Nkya Watoky MMM, Theisen Michael, Vestergaard Lasse S, Jensen Anja TR, Staalsoe Trine, Theander Thor G, Bygbjerg Ib C, Alifrangis Michael

Primary Institution: Centre for Medical Parasitology, University of Copenhagen

Hypothesis

Does acquired immunity enhance the efficacy of malaria treatment in children infected with Plasmodium falciparum?

Conclusion

GLURP-specific IgG antibodies contribute to the clearance of drug-resistant malaria infections in children.

Supporting Evidence

  • 68% of children treated with SP experienced treatment failure.
  • Anti-GLURP-IgG antibodies were significantly higher in children with adequate clinical response.
  • Children with higher levels of anti-GLURP antibodies had a lower prevalence of drug-resistant haplotypes.

Takeaway

The study found that children with certain antibodies were better at fighting off malaria, even when the malaria was resistant to drugs.

Methodology

100 children with uncomplicated malaria were treated with either SP or AQ and followed for 28 days, assessing mutations in parasite genes and antibody responses.

Limitations

The study suggests the need for larger sample sizes and variations in transmission intensity for confirmation.

Participant Demographics

Children aged 6-59 months from a malaria-endemic area in Tanzania.

Statistical Information

P-Value

0.02

Confidence Interval

25.3–36

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1475-2875-6-153

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication